Close Menu

NEW YORK – Startup 54gene, which plans to focus on genomics of Africans, said this week that it has raised $4.5 million in seed funding.

Investors in the firm include Y Combinator, Fifty Years, Better Ventures, KdT Ventures, Hack VC, Pioneer Fund, and Techammer.

The company, founded earlier this year and based in San Francisco and in Lagos, Nigeria, plans to address the fact that only 2 percent of human DNA samples used in pharmaceutical research today are from Africans or those of African ancestry, who have much greater genetic diversity than other human populations.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A Harvard University professor has been charged with making false claims regarding funds he received from China, the New York Times reports.

Discover magazine reports that animal dissections might dissuade students from science careers, but that a firm has developed synthetic frogs for dissections.

Nature News reports that a US panel is reviewing current guidelines for federally funded gain-of-function viral research.

In PNAS this week: de novo mutation patterns among the Amish, an alternative RNA-seq method, and more.